IGHE and chronic rhinosinusitis with nasal polyps: As of October 10, 2022, there have been 16 randomized, double-blind, placebo-controlled trials performed using biologics that target the aforementioned inflammatory mediators and one trial is currently underway that targets IgE in CRSwNP patients.